Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marine Gilabert

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2021
Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trialClaire Gallois, Jean-François Emile, Stefano Kim, et al.
Ebiomedicine|July 7, 2020
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancerRémy Nicolle, Yuna Blum, Pauline Duconseil, et al.
EMBO Molecular Medicine|March 10, 2017
Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine effortsBenjamin Bian, Martin Bigonnet, Odile Gayet, et al.
Nature Communications|May 19, 2018
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypesGwen Lomberk, Yuna Blum, Rémy Nicolle, et al.
Genome Medicine|May 19, 2021
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trialFrançois Bertucci, Anthony Gonçalves, Arnaud Guille, et al.
Cell Reports|November 30, 2017
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived XenograftsRémy Nicolle, Yuna Blum, Laetitia Marisa, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 3, 2021
Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trialClaire Gallois, Jean-François Emile, Stefano Kim, et al.
Ebiomedicine|July 7, 2020
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancerRémy Nicolle, Yuna Blum, Pauline Duconseil, et al.
EMBO Molecular Medicine|March 10, 2017
Gene expression profiling of patient-derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine effortsBenjamin Bian, Martin Bigonnet, Odile Gayet, et al.
Nature Communications|May 19, 2018
Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypesGwen Lomberk, Yuna Blum, Rémy Nicolle, et al.
Genome Medicine|May 19, 2021
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trialFrançois Bertucci, Anthony Gonçalves, Arnaud Guille, et al.
Cell Reports|November 30, 2017
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived XenograftsRémy Nicolle, Yuna Blum, Laetitia Marisa, et al.
Pageof 7